Patents by Inventor Mohammad Ashty Saleh

Mohammad Ashty Saleh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified release formulations of a bupropion salt
    Patent number: 9504640
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: November 29, 2016
    Assignee: Valeant Pharmaceuticals Luxembourg S.Á.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • Modified Release Formulations Of A Bupropion Salt
    Publication number: 20150202147
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 23, 2015
    Applicant: VALEANT INTERNATIONAL BERMUDA
    Inventors: Werner OBEREGGER, Fang ZHOU, Paul MAES, Stefano TURCHETTA, Graham JACKSON, Pietro MASSARDO, Mohammad Ashty SALEH
  • Modified release formulations of a bupropion salt
    Patent number: 8932628
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: January 13, 2015
    Assignee: Valeant International Bermuda
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
    Publication number: 20130266650
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 10, 2013
    Inventors: Graham JACKSON, Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • Modified-release formulations of a bupropion salt
    Patent number: 7884136
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: February 8, 2011
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
    Publication number: 20100255094
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Application
    Filed: October 28, 2008
    Publication date: October 7, 2010
    Applicant: BIOVAIL LABORATORIES INTERNATIONAL SRL
    Inventors: Graham Jackson, Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • MODIFIED-RELEASE FORMULATIONS OF A BUPROPION SALT
    Publication number: 20100222435
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Application
    Filed: June 27, 2006
    Publication date: September 2, 2010
    Applicant: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7662407
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: February 16, 2010
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7649019
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: January 19, 2010
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • Bupropion hydrobromide and therapeutic applications
    Patent number: 7645802
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: January 12, 2010
    Assignee: Biovail Laboratories International SRL.
    Inventors: Werner Oberegger, Paul Maes, Mohammad Ashty Saleh, Graham Jackson
  • Modified release formulations of a bupropion salt
    Patent number: 7645901
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: January 12, 2010
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Paul Maes, Stefano Turchetta, Pietro Massardo, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7585897
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: September 8, 2009
    Assignee: Biovail Laboratories International S.r.l.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7579380
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: August 25, 2009
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7572935
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: August 11, 2009
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Paul Maes, Stefano Turchetta, Pietro Massardo, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7569610
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: August 4, 2009
    Assignee: Biovail Laboratories International SRL
    Inventors: Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7569611
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: August 4, 2009
    Assignee: Biovail Laboratories International SRL.
    Inventors: Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7563823
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: July 21, 2009
    Assignee: Biovail Laboratories International SRL.
    Inventors: Werner Oberegger, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • Modified release formulations of a bupropion salt
    Patent number: 7553992
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: June 30, 2009
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Paul Maes, Stefano Turchetta, Pietro Massardo, Mohammad Ashty Saleh
  • BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
    Publication number: 20080274181
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Application
    Filed: October 31, 2007
    Publication date: November 6, 2008
    Applicant: BIOAVAIL LABORATORIES INTERNATIONAL S.R.L.
    Inventors: Paul Maes, Werner Oberegger, Mohammad Ashty Saleh
  • MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT
    Publication number: 20080038348
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Application
    Filed: June 13, 2007
    Publication date: February 14, 2008
    Applicant: BIOAVAIL LABORATORIES INTERNATIONAL S.R.L.
    Inventors: Werner OBEREGGER, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh